Lv4
480 积分 2025-12-16 加入
Hallmarks of cancer—Then and now, and beyond
15小时前
已完结
Slipknot-gauged mechanical transmission and robotic operation
3天前
已完结
Advancing regulatory variant effect prediction with AlphaGenome
5天前
已完结
A generative vision-language model for holistic pathological assessment using preoperative imaging in hepatocellular carcinoma
6天前
已完结
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR
6天前
已完结
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
8天前
已完结
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
9天前
已关闭
WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
9天前
已完结
SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study
13天前
已关闭
Cancer statistics, 2026
15天前
已完结
皖公网安备34019202002308
